Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer - Reply

被引:0
|
作者
不详
机构
来源
JOURNAL OF UROLOGY | 2001年 / 165卷 / 05期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1467 / 1467
页数:1
相关论文
共 50 条
  • [1] Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer
    Sánchez-Carbayo, M
    Urrutia, M
    Silva, JM
    Romaní, R
    De Buitrago, JMG
    Navajo, JA
    JOURNAL OF UROLOGY, 2001, 165 (05): : 1462 - 1466
  • [2] Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer - Comment
    Droller, MJ
    JOURNAL OF UROLOGY, 2001, 165 (05): : 1466 - 1467
  • [3] Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22*to detect bladder cancer
    Sánchez-Carbayo, M
    Herrero, E
    Megías, J
    Mira, A
    Soria, F
    JOURNAL OF UROLOGY, 1999, 162 (06): : 1951 - 1956
  • [4] Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22*to detect bladder cancer - Comment
    Grossman, HB
    JOURNAL OF UROLOGY, 1999, 162 (06): : 1956 - 1956
  • [5] Comparative role of urinary NMP22, CYFRA 21-1, quantitative and qualitative UBC and TPA in the diagnosis of bladder cancer.
    Sánchez-Carbayo, M
    Herrero, E
    Megías, J
    Mira, A
    Molina, R
    Soria, F
    CLINICAL CHEMISTRY, 1999, 45 (06) : A116 - A117
  • [6] Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer
    Jeong, Seri
    Park, Yongjung
    Cho, Yonggeun
    Kim, Young Ran
    Kim, Hyon-Suk
    CLINICA CHIMICA ACTA, 2012, 414 : 93 - 100
  • [7] Urinary NMP22® BladderChek® test in the diagnosis of superficial bladder cancer
    Moonen, PMJ
    Kiemeney, LALM
    Witjes, JA
    EUROPEAN UROLOGY, 2005, 48 (06) : 951 - 956
  • [8] NMP22 IS PREDICTIVE OF RECURRENCE IN HIGH RISK SUPERFICIAL BLADDER CANCER PATIENTS
    Yau, Paul
    Chin, Joseph L.
    Pautler, Stephen
    Razvi, Hassan
    Izawa, Jonathan I.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 641 - 641
  • [9] Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors
    Giannopoulos, A
    Manousakas, T
    Gounari, A
    Constantinides, C
    Choremi-Papadopoulou, H
    Dimopoulos, C
    JOURNAL OF UROLOGY, 2001, 166 (02): : 470 - 475
  • [10] NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
    Lau, Paul
    Chin, Joseph L.
    Pautler, Stephen
    Razvi, Hassan
    Izawa, Jonathan I.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (06): : 454 - 458